A. Lowering BP (BP) with a combination of drugs that includes an angiotensinconverting enzyme (ACE) inhibitor is superior to using any other agents, even if the BP is close to, but not at, goal levels. B. Lowering BP with any combination of agents will reduce cardiovascular risk if the BP is at goal levels. C. Use of a diuretic/ß-blocker combination is the only therapy that has been shown in clinical trials to effectively reduce cardiovascular risk regardless of the BP achieved. D. Risk for cardiovascular events plateaus at BP levels above 180 mmHg. E. A J-shaped curve relative to the occurrence of cardiovascular events exists for BP-lowering in people under the age of 50 years.
KeywordsContinuous Positive Airway Pressure Correct Answer Primary Aldosteronism Pediatric Nephrology White Coat Hypertension
Unable to display preview. Download preview PDF.
- The Diabetes Prevention Program (DDP): description of lifestyle intervention. Diabetes Care 25:2165–2171Google Scholar
- Sacks FM, Svetky LP, Vollmer WM, et al. (2001) Effects on BP of reduced dietary sodium and the Dietary Approaches to stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 344:3–10Google Scholar
- Douglas JG, Bakris GL, Epstien M, et al. (2003) Management of high BP in African Americans: Consensus statements of the hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med 163:541–541Google Scholar
- Brown RD (2003) Treatment of hypertensive patients with cerebrovascular disease. In; Izzo J and Black HR (eds): Hypertension Primer. Lippincott, Williams and Wilkins Dallas, pp.476–477Google Scholar
- Logan AC, Perlikowski SM, Mente A (2001) Prevalence of unrecognized sleep apnea in drug-resistant hypertension. J Hypertension 19:2271–1177Google Scholar
- K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 43:1–290Google Scholar